The Effect of Haptonomy Practice on Body Functionality Appreciation and Childbirth Self-Efficacy in Pregnant Women
Condition(s) studied
Investigational drug(s) / intervention(s)
Haptonomy: Pregnant participants will receive a four-session haptonomy intervention, each lasting approximately 45 minutes. The sessions aim to enhance body awareness, reduce childbirth-related anxiety, and support birth self-efficacy. The intervention includes breathing exercises, relaxation techniques, and activities promoting maternal-fetal interaction.
Study summary
Study Type and Aim:
This clinical study aims to examine the effects of haptonomy practices on appreciation of bodily functionality and childbirth self-efficacy among healthy pregnant women. The study seeks to determine whether haptonomy can enhance these two outcomes.
Key Research Questions:
Do haptonomy practices increase appreciation of bodily functionality in pregnant women? Do haptonomy practices increase childbirth self-efficacy in pregnant women?
Comparison:
Researchers will compare an intervention group receiving haptonomy sessions with a control group receiving only routine prenatal care to evaluate the effects of the intervention.
Participants will:
Participants will provide written informed consent to take part in the study. Pregnant women in the intervention group will attend four haptonomy sessions, each lasting approximately 45 minutes and held at 7-day intervals. Sessions will include practices to enhance body awareness, relaxation techniques, connecting with the baby, and affirmations supporting bodily functionality and childbirth self-efficacy.
Pregnant women in the control group will receive routine prenatal care and follow-up only.
All participants will complete pretest and posttest measures assessing appreciation of bodily functionality and childbirth self-efficacy.
Keywords: Haptonomy, Vaginal birth, Pregnancy, Prenatal care, Body functionality appreciation, Birth self-efficacy
Eligibility
Primary outcome measure(s)
- The sociodemographic characteristics of the participants and their homogeneous distribution according to the experimental and control groups — baseline
Pregnancy Introductory Form: The pregnancy introductory form, developed based on the literature, was designed to evaluate the demographic and obstetric characteristics of individuals during pregnancy, their birth preferences, fears, social support status, and similar factors. The form consists of a total of 15 questions. - Body Functionality Appreciation Scale: — 12 weeks
This unidimensional 7-item scale measures individuals' appreciation of their body's functionality. It evaluates psychological aspects such as body functionality awareness, body positivity, and body acceptance. The scale is scored on a 5-point Likert scale (1=Strongly disagree, 5=Strongly agree), with total scores ranging from 7 to 35. Higher scores indicate a greater level of appreciation and respect for what one's body can do. The Turkish adaptation reported a Cronbach's alpha of 0.83. - Birth Self-Efficacy Inventory: — 12 weeks
This inventory measures self-efficacy levels during labor. It consists of two subscales: outcome expectancy (OE) and efficacy expectancy (EE), each containing 16 items. Total scores range from 32 to 320. Responses are rated on a 1-10 Likert scale. In the OE subscale, 1 means "not at all useful" and 10 means "very useful." In the first 13 items of the EE subscale, 1 means "completely sure" and 10 means "not at all sure," while items 14-16 are scored in reverse: 1 means "not at all sure" and 10 means "completely sure." Items 1-13 of the EE subscale are reverse-scored. The overall Cronbach's alpha reliability coefficient of the inventory is 0.82.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Gaziosmanpaşa University, Erbaa Faculty of Health Sciences | Erbaa | Tokat Province |
More Tokat Gaziosmanpasa University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07199140 on ClinicalTrials.gov ↗ ← All trials in Turkey